PMC:7172841 / 11339-11499 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T48","span":{"begin":94,"end":97},"obj":"Body_part"},{"id":"T49","span":{"begin":115,"end":124},"obj":"Body_part"}],"attributes":[{"id":"A48","pred":"fma_id","subj":"T48","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A49","pred":"fma_id","subj":"T49","obj":"http://purl.org/sig/ont/fma/fma62864"}],"text":"Among patients with bacterial CAP at an intermediate immune state, the number of molecules of HLA-DR on their CD14 monocytes was lower than in healthy patients."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T68","span":{"begin":115,"end":124},"obj":"http://purl.obolibrary.org/obo/CL_0000576"}],"text":"Among patients with bacterial CAP at an intermediate immune state, the number of molecules of HLA-DR on their CD14 monocytes was lower than in healthy patients."}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T53","span":{"begin":81,"end":90},"obj":"Chemical"},{"id":"T54","span":{"begin":98,"end":100},"obj":"Chemical"}],"attributes":[{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_25367"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"Among patients with bacterial CAP at an intermediate immune state, the number of molecules of HLA-DR on their CD14 monocytes was lower than in healthy patients."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T93","span":{"begin":0,"end":160},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Among patients with bacterial CAP at an intermediate immune state, the number of molecules of HLA-DR on their CD14 monocytes was lower than in healthy patients."}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T204","span":{"begin":20,"end":29},"obj":"NCBITaxon:2"},{"id":"T205","span":{"begin":53,"end":59},"obj":"UBERON:0002405"},{"id":"T206","span":{"begin":81,"end":90},"obj":"CHEBI:36357;CHEBI:36357"},{"id":"T207","span":{"begin":94,"end":97},"obj":"PR:000029150"},{"id":"T208","span":{"begin":110,"end":114},"obj":"PR:000001889"},{"id":"T209","span":{"begin":115,"end":124},"obj":"CL:0000576"},{"id":"T98490","span":{"begin":149,"end":153},"obj":"PR:000001002"},{"id":"T81900","span":{"begin":154,"end":158},"obj":"PR:000001006"}],"text":"Among patients with bacterial CAP at an intermediate immune state, the number of molecules of HLA-DR on their CD14 monocytes was lower than in healthy patients."}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"430","span":{"begin":110,"end":114},"obj":"Gene"},{"id":"439","span":{"begin":6,"end":14},"obj":"Species"},{"id":"440","span":{"begin":151,"end":159},"obj":"Species"}],"attributes":[{"id":"A430","pred":"tao:has_database_id","subj":"430","obj":"Gene:929"},{"id":"A439","pred":"tao:has_database_id","subj":"439","obj":"Tax:9606"},{"id":"A440","pred":"tao:has_database_id","subj":"440","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Among patients with bacterial CAP at an intermediate immune state, the number of molecules of HLA-DR on their CD14 monocytes was lower than in healthy patients."}